(Q43233650)

16 November 2017

Quercetin supplementation does not alter antioxidant status in humans (English)

1 reference

16 November 2017

R Andrew Shanely

1

1 reference

16 November 2017

Amy M Knab

2

1 reference

16 November 2017

David C Nieman

3

1 reference

16 November 2017

Fuxia Jin

4

1 reference

16 November 2017

Steven R McAnulty

5

1 reference

16 November 2017

Michael J Landram

6

1 reference

16 November 2017

1 February 2010

1 reference

16 November 2017

Free Radical Research

1 reference

16 November 2017

44

1 reference

16 November 2017

224-231

1 reference

16 November 2017

2

1 reference

Flavonol and flavone intakes in US health professionals

16 November 2017

1 reference

https://api.crossref.org/works/10.3109%2F10715760903407293

In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-kappaB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715760903407293

The flavonoid quercetin inhibits proinflammatory cytokine (tumor necrosis factor alpha) gene expression in normal peripheral blood mononuclear cells via modulation of the NF-kappa beta system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715760903407293

In vitro antiviral activities of Caesalpinia pulcherrima and its related flavonoids

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715760903407293

Safety-assessment of 3-methoxyquercetin as an antirhinoviral compound for nasal application: effect on ciliary beat frequency

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715760903407293

Quercetin reduces susceptibility to influenza infection following stressful exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715760903407293

Antimicrobial activity of flavonoids

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715760903407293

Dietary flavonoids and cancer risk: evidence from human population studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715760903407293

Quercetin increases brain and muscle mitochondrial biogenesis and exercise tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715760903407293

Quercetin pharmacokinetics in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715760903407293

A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715760903407293

Evaluation of the potential in vivo genotoxicity of quercetin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715760903407293

Effects of quercetin and EGCG on mitochondrial biogenesis and immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715760903407293

Antioxidant evaluation of O-methylated metabolites of catechin, epicatechin and quercetin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715760903407293

Structure-antioxidant activity relationships of flavonoids and phenolic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715760903407293

Inhibition of human low density lipoprotein oxidation by flavonols and their glycosides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715760903407293

Quercetin and its in vivo metabolites inhibit neutrophil-mediated low-density lipoprotein oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715760903407293

Plasma quercetin metabolites: structure-antioxidant activity relationships.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715760903407293

Quercetin up-regulates paraoxonase 1 gene expression with concomitant protection against LDL oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715760903407293

Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and beta-cell damage in rat pancreas.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715760903407293

Identification of quercetin 3-O-beta-D-glucuronide as an antioxidative metabolite in rat plasma after oral administration of quercetin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715760903407293

Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715760903407293

Oral quercetin supplementation and blood oxidative capacity in response to ultramarathon competition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715760903407293

In vitro and ex vivo anti-inflammatory activity of quercetin in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715760903407293

F2-isoprostanes in human health and diseases: from molecular mechanisms to clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715760903407293

Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715760903407293

Clinical oxidation parameters of aging

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715760903407293

Chronic quercetin ingestion and exercise-induced oxidative damage and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715760903407293

Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715760903407293

The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715760903407293

Oxygen-radical absorbance capacity assay for antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715760903407293

Consumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans: cause, consequence, or epiphenomenon?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715760903407293

Metabolic transformation has a profound effect on anti-inflammatory activity of flavonoids such as quercetin: lack of association between antioxidant and lipoxygenase inhibitory activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715760903407293

Pharmacokinetics and bioavailability of the bioflavonoid biochanin A: effects of quercetin and EGCG on biochanin A disposition in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715760903407293

Intestinal anti-inflammatory activity of combined quercitrin and dietary olive oil supplemented with fish oil, rich in EPA and DHA (n-3) polyunsaturated fatty acids, in rats with DSS-induced colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715760903407293

Protective effects of a combination of quercetin and vitamin E against cyclosporine A-induced oxidative stress and hepatotoxicity in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715760903407293

10.3109/10715760903407293

21 January 2018

Identifiers

DOI

1 reference

16 November 2017

1 reference